2018
DOI: 10.1002/da.22746
|View full text |Cite
|
Sign up to set email alerts
|

A systematic review and meta-analysis of deep brain stimulation for depression

Abstract: DBS may show promise for treatment-resistant depression but remains an experimental treatment until further data are available.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

1
74
0
3

Year Published

2018
2018
2023
2023

Publication Types

Select...
6
2
1

Relationship

0
9

Authors

Journals

citations
Cited by 125 publications
(78 citation statements)
references
References 38 publications
1
74
0
3
Order By: Relevance
“…Deep brain stimulation (DBS) is an invasive neurosurgical intervention that involves the continuous delivery of electrical impulses (through typically 2 bilaterally implanted electrodes) to the critical brain area believed to drive the pathological activity. Given that DBS was proven to be a safe and highly effective treatment for controlling the motor symptoms associated with movement disorders [9], clinicians have taken considerable interest in employing DBS in some circuit-based psychiatric disorders, such as major depression [10] and AN [11e14]. Previously, we suggested the DBS of the nucleus accumbens (NAcc), i.e., a subcomponent of the ventral striatum, to be a relatively safe and valuable option for weight restoration in patients with refractory AN [12].…”
Section: Introductionmentioning
confidence: 99%
“…Deep brain stimulation (DBS) is an invasive neurosurgical intervention that involves the continuous delivery of electrical impulses (through typically 2 bilaterally implanted electrodes) to the critical brain area believed to drive the pathological activity. Given that DBS was proven to be a safe and highly effective treatment for controlling the motor symptoms associated with movement disorders [9], clinicians have taken considerable interest in employing DBS in some circuit-based psychiatric disorders, such as major depression [10] and AN [11e14]. Previously, we suggested the DBS of the nucleus accumbens (NAcc), i.e., a subcomponent of the ventral striatum, to be a relatively safe and valuable option for weight restoration in patients with refractory AN [12].…”
Section: Introductionmentioning
confidence: 99%
“…Deep brain stimulation for the treatment of major depressive disorder (MDD) is a rather new indication offering hope for some of these treatment resistant patients. A first uncontrolled case series studied effects of DBS to Brodman area 25 (cg25, later termed SCG = subgenual cingulate gyrus) (Mayberg et al, 2005) and the scg target is likely the most frequently implanted structure in this disease (Kisely et al, 2018). Other target regions have been researched (ALIC = anterior limb of the internal capsule; vc/vs = ventral capsule ventral striatum for which case series exist and some smaller case series or even single case reports for structures like inferior thalamic peduncle, habenula and others).…”
Section: Introductionmentioning
confidence: 99%
“…Other target regions have been researched (ALIC = anterior limb of the internal capsule; vc/vs = ventral capsule ventral striatum for which case series exist and some smaller case series or even single case reports for structures like inferior thalamic peduncle, habenula and others). For a review on the topic refer to (Hariz et al, 2013; Kisely et al, 2018). Two pivotal randomized controlled multicentric trials were recently stopped after futility analysis (Dougherty et al, 2015; Holtzheimer et al, 2017).…”
Section: Introductionmentioning
confidence: 99%
“…Thus, we believe that those patients resistant to current standards of care might benefit from the use of novel neurotechnologies like DBS. However, randomized control trials of using continuous DBS of pre-selected brain locations to treat major depression, while relatively efficacious, did not yield statistically significant results (Kisely et al, 2018). Difficulties in treating depression with DBS may be related to the complex and heterogeneous nature of this disorder.…”
Section: A Randomized Controlled Trial Of Personalized Adaptive-loop mentioning
confidence: 99%